These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 2478982)

  • 21. Electrophysiology and antiarrhythmic efficacy of intravenous pirmenol in patients with sustained ventricular tachyarrhythmias.
    Liem LB; Clay DA; Franz MR; Swerdlow CD
    Am Heart J; 1987 Jun; 113(6):1390-6. PubMed ID: 3591608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term efficacy of mexiletine alone and in combination with class Ia antiarrhythmic drugs for refractory ventricular arrhythmias.
    Whitford EG; McGovern B; Schoenfeld MH; Garan H; Newell JB; McElroy M; Ruskin JN
    Am Heart J; 1988 Feb; 115(2):360-6. PubMed ID: 3341170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of isoproterenol on sustained ventricular tachycardia before and during procainamide and quinidine antiarrhythmic drug therapy.
    Markel ML; Miles WM; Luck JC; Klein LS; Prystowsky EN
    Circulation; 1993 Mar; 87(3):783-92. PubMed ID: 8443899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meobentine sulfate: antiarrhythmic and electrophysiologic effects assessed by programmed electrical stimulation and ambulatory monitoring in patients with complex ventricular tachyarrhythmia. Report of a multicenter evaluation.
    Anderson JL; Reid PR; Platia EV; Akhtar M; Ruskin JN; Schaal SF; Jueng P; Long RA; Wenger TL
    Am Heart J; 1985 Oct; 110(4):774-84. PubMed ID: 3901715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Anti-arrhythmia and pro-arrhythmia effects of oral cibenzoline therapy in sustained ventricular tachycardia].
    Hoffmann E; Bach P; Haberl R; Mattke S; Steinbeck G
    Z Kardiol; 1992 Jul; 81(7):378-84. PubMed ID: 1509795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Results of electrophysiological testing and long-term follow-up in patients sustaining cardiac arrest only while receiving type IA antiarrhythmic agents.
    Hook BG; Rosenthal ME; Marchlinski FE; Buxton AE; Josephson ME
    Pacing Clin Electrophysiol; 1992 Mar; 15(3):324-33. PubMed ID: 1372727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug response at electropharmacologic study in patients with ventricular tachyarrhythmias: the importance of ventricular refractoriness.
    Gillis AM; Wyse DG; Duff HJ; Mitchell LB
    J Am Coll Cardiol; 1991 Mar; 17(4):914-20. PubMed ID: 1999629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electrophysiologic evaluation of pirmenol for sustained ventricular tachycardia secondary to coronary artery disease.
    Easley AR; Mann DE; Reiter MJ; Sakun V; Sullivan SM; Magro SA; Luck JC; Wyndham CR
    Am J Cardiol; 1986 Jul; 58(1):86-9. PubMed ID: 3728337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Combination of celiprolol and amiodarone in the treatment of recurrent ventricular tachycardia].
    Tonet J; Hidden F; Naditch L; Coutte R; Himbert C; Frank R
    Ann Cardiol Angeiol (Paris); 1996 Jan; 45(1):18-23. PubMed ID: 8815771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
    Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB
    Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Graded criteria to assess the effectiveness of anti-arrhythmia therapy in patients with ventricular tachyarrhythmia by serial electrophysiological testing].
    Borggrefe M; Breithardt G
    Z Kardiol; 1986 Feb; 75(2):70-9. PubMed ID: 3705680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiarrhythmic efficacy, clinical electrophysiology, and pharmacokinetics of 3-methoxy-O-desmethyl encainide (MODE) in patients with inducible ventricular tachycardia or fibrillation.
    Roden DM; Lee JT; Woosley RL; Echt DS
    Circulation; 1989 Nov; 80(5):1247-58. PubMed ID: 2805262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of oral sotalol for sustained ventricular tachyarrhythmias refractory to other antiarrhythmic agents.
    Kehoe RF; MacNeil DJ; Zheutlin TA; Ezri MD; Nazari J; Spangenberg RB; Dunnington C; Lueken M
    Am J Cardiol; 1993 Aug; 72(4):56A-66A. PubMed ID: 8346728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of nonsustained ventricular tachycardia guided by electrophysiological testing.
    Kadish A; Schmaltz S; Calkins H; Morady F
    Pacing Clin Electrophysiol; 1993 May; 16(5 Pt 1):1037-50. PubMed ID: 7685883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical efficacy and electropharmacology of continuous intravenous amiodarone infusion and chronic oral amiodarone in refractory ventricular tachycardia.
    Saksena S; Rothbart ST; Shah Y; Cappello G
    Am J Cardiol; 1984 Aug; 54(3):347-52. PubMed ID: 6465016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy, electrophysiologic and electrocardiographic effects of intravenous pirmenol, a new class I antiarrhythmic agent, in patients with ventricular tachycardia: comparison with procainamide.
    Gold RL; Frumin H; Haffajee CI; Kerin NZ; Jarandilla R
    Pacing Clin Electrophysiol; 1988 Mar; 11(3):308-14. PubMed ID: 2452418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Slowing of ventricular tachycardia as a possible endpoint for serial drug testing at electrophysiological study.
    Handlin LR; Brodine WN; Gibbs H; Vacek JL
    Pacing Clin Electrophysiol; 1992 Jun; 15(6):864-9. PubMed ID: 1376898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrophysiologic and antiarrhythmic efficacy of oral sotalol for sustained ventricular tachyarrhythmias: evaluation by programmed stimulation and ambulatory electrocardiogram.
    Steinbeck G; Bach P; Haberl R
    J Am Coll Cardiol; 1986 Oct; 8(4):949-58. PubMed ID: 3760368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nadolol and supraventricular tachycardia: an electrophysiologic study.
    Chang MS; Sung RJ; Tai TY; Lin SL; Liu PH; Chiang BN
    J Am Coll Cardiol; 1983 Nov; 2(5):894-903. PubMed ID: 6138376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term efficacy of d/l sotalol in patients with sustained ventricular tachycardia refractory to class I antiarrhythmic drugs.
    Kühlkamp V; Mermi J; Mewis C; Braun U; Seipel L
    Eur Heart J; 1995 Nov; 16(11):1625-31. PubMed ID: 8881857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.